blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1853268

EP1853268 - USE OF SODIUM CHANNEL BLOCKERS AND THEIR ANALOGUES FOR THE TREATMENT OF NICOTINE DEPENDENCY [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  03.04.2009
Database last updated on 16.07.2024
Most recent event   Tooltip03.04.2009Application deemed to be withdrawnpublished on 06.05.2009  [2009/19]
Applicant(s)For all designated states
Wex Pharmaceuticals Inc.
1601-700 West Pender Street
Vancouver, BC V6C 1G8 / CA
[2007/46]
Inventor(s)01 / BUSCHMANN, Helmut Henrich
Carrer dels Avellaners, 11
08960 San Just Desvern (Barcelona) / ES
02 / FARRE GOMIS, Antonio
Roger de Llúria, 149 - 1º B
E-08037 Barcelona / ES
03 / VELA HERNÁNDEZ, José Miguel
Avda. Badal, 153 - 8º 3ª
E-08028 Barcelona / ES
 [2008/03]
Former [2007/46]01 / BUSCHMANN, Helmut Henrich
Est, 24, E-08950 Espluguees de Llobregat
Barcelona / ES
02 / FARRE GOMIS, Antonio
Roger de Llúria, 149 - 1º B
E-08037 Barcelona / ES
03 / VELA HERNÁNDEZ, José Miguel
Avda. Badal, 153 - 8º 3ª
E-08028 Barcelona / ES
Representative(s)ABG Intellectual Property Law, S.L.
Avenida de Burgos, 16D
Edificio Euromor
28036 Madrid / ES
[N/P]
Former [2008/36]ABG Patentes, S.L.
Avenida de Burgos 16D Edificio Euromor
28036 Madrid / ES
Former [2007/46]ABG Patentes, S.L.
Avenida de Burgos, 16D 4th floor Edificio Euromor
28036 Madrid / ES
Application number, filing date06706929.410.02.2006
[2007/46]
WO2006EP01322
Priority number, dateEP2005038400111.02.2005         Original published format: EP 05384001
EP2005038400222.04.2005         Original published format: EP 05384002
[2007/46]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2006084765
Date:17.08.2006
Language:EN
[2006/33]
Type: A1 Application with search report 
No.:EP1853268
Date:14.11.2007
Language:EN
The application published by WIPO in one of the EPO official languages on 17.08.2006 takes the place of the publication of the European patent application.
[2007/46]
Search report(s)International search report - published on:EP17.08.2006
ClassificationIPC:A61K31/529, A61K31/465, A61K31/52, A61P25/34
[2007/46]
CPC:
A61K31/465 (EP); A61K31/52 (EP); A61K31/529 (EP);
A61P25/00 (EP); A61P25/34 (EP)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2007/46]
Extension statesALNot yet paid
BANot yet paid
HRNot yet paid
MKNot yet paid
YUNot yet paid
TitleGerman:VERWENDUNG VON NATRIUMKANALBLOCKERN UND IHRER ANALOGA ZUR BEHANDLUNG VON NIKOTIN-ABHÄNGIGKEIT[2007/46]
English:USE OF SODIUM CHANNEL BLOCKERS AND THEIR ANALOGUES FOR THE TREATMENT OF NICOTINE DEPENDENCY[2007/46]
French:UTILISATION D'UN INHIBITEUR DE CANAUX SODIQUES ET LEUR ANALOGUES POUR LE TRAITEMENT DE LA DÉPENDANCE À LA NICOTINE[2007/46]
Entry into regional phase10.09.2007National basic fee paid 
10.09.2007Designation fee(s) paid 
10.09.2007Examination fee paid 
Examination procedure10.09.2007Examination requested  [2007/46]
05.05.2008Despatch of a communication from the examining division (Time limit: M06)
18.11.2008Application deemed to be withdrawn, date of legal effect  [2009/19]
19.12.2008Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2009/19]
Fees paidRenewal fee
21.01.2008Renewal fee patent year 03
Penalty fee
Additional fee for renewal fee
28.02.200904   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[DXA]EP0750909  (NANNING MAPLE LEAF PHARMACEUTI [CN]) [DX] 13 * the whole document * [A] 1-15;
 [DXA]WO0222129  (WEX MEDICAL INSTRUMENTATION CO [CN], et al) [DX] 13 * example 1 * * claim - * [A] 1-15;
 [A]  - ROSE J E, "Nicotine addiction and treatment", ANNUAL REVIEW OF MEDICINE : SELECTED TOPICS IN THE CLINICAL SCIENCES, ANNUAL REVIEWS INC., PALO ALTO, CA, US, (1996), vol. 47, ISSN 0066-4219, pages 493 - 507, XP002111224 [A] 1-15 * page 497, column 502 *

DOI:   http://dx.doi.org/10.1146/annurev.med.47.1.493
 [A]  - ANGER T ET AL, "MEDICINAL CHEMISTRY OF NEURONAL VOLTAGE-GATED SODIUM CHANNEL BLOCKERS", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY. WASHINGTON, US, (20010118), vol. 44, no. 2, ISSN 0022-2623, pages 115 - 137, XP009049196 [A] 1-15 * the whole document *

DOI:   http://dx.doi.org/10.1021/jm000155h
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.